Stock Details
4768.T is Otsuka Corporation's stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 4,510.10ï¿¥. Average daily volumn in 3 months 565.87k. Market cap 857.95B

Stock symbol : 4768.T. Exchange : Tokyo. Currency : JPY
Lastest price : 4,525.00ï¿¥. Total volume : 620.30k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Otsuka Corporation (4768.T)
Last Price

Previous Close4,535.00
Day Range4,525.00-4,595.00
Bid4,520.00 x N/A
Ask4,540.00 x N/A
Average Volume565.87k
Market Cap857.95B
52 Week Range3,690.00-5,880.00
Trailing P/E21.93
Foward P/E20.60
Dividend (Yield %)N/A
Ex-Dividend DateN/A

Financial Details

According to Otsuka Corporation's financial reports the company's revenue in 2021 were 851.89B an increase( +1.79%) over the years 2020 revenue that were of 836.32B. In 2021 the company's total earnings were 39.93B while total earnings in 2020 were 39.31B(0%).

Loading ...


Market Cap:
Total Assets:
Total Cash:

News about "Otsuka Corporation"

Otsuka Corporation (4768.T)

Source from : Yahoo Finance - 7 days ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»

Otsuka Information Technology Corp

Source from : Reuters - 12 days ago

Otsuka Information Technology Corp. is a Taiwan-based company primarily engaged in research and development, design and distribution of three dimensional (3D) computer-aided design (CAD ...See details»

Otsuka, Aurinia claim EU okay for oral lupus nephritis drug

Source from : pharmaphorum - 11 days ago

Otsuka licensed rights to Lupkynis in various ex-US markets including the EU, Japan and the UK in 2020, with Aurinia retaining rights to the drug in the US and its home market of Canada.See details»

Otsuka and Aurinia's Lupkynis granted EC approval as active lupus nephritis treatment

Source from : PMLiVE - 11 days ago

Otsuka Pharmaceutical Europe (Otsuka) and Aurinia Pharmaceuticals (Aurinia) have received approval from the European Commission (EC) for Lupkynis (voclosporin) for use in combination with ...See details»

Otsuka announces EC approval of Lupkynis® (voclosporin) as first oral treatment for active lupus nephritis

Source from : PharmiWeb - 11 days ago

LONDON, UK, 20 September 2022 – Otsuka Pharmaceutical Europe Ltd. today announces that the European Commission (EC) has approved Lupkynis ® (voclosporin) in combination with mycophenolate mofetil for ...See details»

International Business Machines Corp

Source from : CNBC - 2 days ago

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and more info about our products and ...See details»

Vyron Corp.

Source from : BizTimes - 8 days ago

Vyron is an HVAC manufacturer’s representative, serving the needs of facility owners, mechanical contractors and mechanical engineers in Wisconsin and the Upper Peninsula of Michigan. Roberta ...See details»

IV Bags Market : Analysis by Size, Share Trends, Future Growth, Emerging Trends, Qualitative Outlook and Global Forecast to 2027

Source from : MarketWatch - 2 days ago

The global IV Bags market size was valued at USD 3129.53 million in 2021 and is expected to expand at a CAGR of ...See details»

Doral Corp.

Source from : BizTimes - 9 days ago

Doral Corp. provides machinery moving and rigging, material handling and metal fabrication services to companies in the food and beverage, construction and manufacturing industries. What ...See details»

Julie Otsuka to talk 'The Swimmers,' writing and more at F&M; here's how to attend

Source from : LancasterOnline - 27 days ago

Twenty years after appearing at the first-ever Franklin & Marshall College Emerging Writers Festival, Julie Otsuka, the New York Times bestselling author of three novels, will soon return to campus.See details»

Nomura Otsuka Group Equity Fund Dc Otsuka Holdings Equity Earth Corp Equity (0P0000UU9U)

Source from : Investing - 5 days ago

© 2007-2022 Fusion Media Limited. All Rights Reserved. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the ...See details»

Ganni achieves B Corp status

Source from : Drapers - 9 days ago

The business said it received 90.6 points following a “rigorous application process”. B Corp certification requires a B Impact Assessment score of more than 80 points. Ganni had to answer more than ...See details»

Should Value Investors Consider TopBuild Corp (BLD) Stock?

Source from : Nasdaq - 22 days ago

Let’s put TopBuild Corp. BLD stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look ...See details»

Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

Source from : Yahoo Finance - 11 days ago

Study of the Paradise™ Ultrasound Renal Denervation System Shows significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension TOKYO, September 20, 2022--(BUSINESS WIRE)--Otsuka ...See details»